Autism / ASD is a neuro-developmental disorder considered by many to be a permanent condition with little hope for improvement. ASD can be associated with intellectual disability, difficulties in motor coordination and attention and physical health issues such as sleep and gastrointestinal disturbances. Treatment for autism is centered on special schooling and behavioral therapy; medical science currently has little to offer.
Most cases of autism appear to be caused by a combination of autism risk genes and environmental factors influencing early brain development. Recent researches show that some autistic individuals have decreased blood flow to the brain, evidence of inflammation in the brain, and increased markers of oxidative stress.
Multiple independent single photon emission computed tomography (SPECT) and positron emission tomography (PET) research studies have revealed hypoperfusion to several areas of the autistic brain, most notably the temporal regions and areas specifically related to language comprehension and auditory processing. Several studies show that diminished blood flow to these areas correlates with many of the clinical features associated with autism including repetitive, self-stimulatory and stereotypical behaviors, and impairments in communication, sensory perception, and social interaction.
HBOT can counter these problems, and can create an amazing sense of wellbeing in the child. Hyperbaric oxygen therapy (HBOT) has a well-known anti-inflammatory effect & and can measurably improve immune function. Multiple studies have shown that oxidative stress can be significantly reduced with HBOT through the up-regulation of anti-oxident enzymes.
There are no drugs to take, no difficult situations to deal with, and it can even be done in your own home. That’s the simplicity of HBOT.
During the course of treatment or upon completion, you will notice improvements in your child. The overall effect is a mental and physical well-being that carries on through life.
Cerebral Palsy (CP) is a descriptive neurological and physical problem originating from defects in motor cortices. Collectively these are labeled as cerebral palsy.
Cerebral Palsy is non-progressive, non-contagious, permanent neurological abnormality. The location and size of the lesion will determine what deficit the child will have. The abnormalities occur in utero, during or after birth up until age five. The affected individual is influenced by genetic and environmental factors as well. Cerebral Palsy is associated with a perinatal hypoxic event (tight nuchal or prolapsed cord), placental abnormalities , prolonged labor, or infection transmitted during delivery.
There is no known cure for cerebral palsy, and there is no standard therapy. Early treatment gives a child a better chance to overcome disabilities. Therapy for the cerebral palsy child integrates physical, occupational and speech therapies, complemented with psychological, social and educational therapies. Many medications are often needed to help with associated cerebral palsy symptoms such as muscular spasms.
Two alternative therapies considered by some to be controversial include neuromuscular electrical stimulation and hyperbaric oxygen therapy (HBOT). HBOT might be beneficial in treating Cerebral Palsy cases that are due to traumatic brain injury caused by decreased oxygen. Genetic or developmental causes of cerebral palsy would not benefit from HBOT.
The theoretical basis for HBOT in CP is that there are areas in the brain next to the CP lesions that are hypoxic due to marginal tissue perfusion. HBOT can increase the available oxygen to these marginal tissues and reactivate the cells to become functional. The number of cells that can be “salvaged” by HBOT cannot be determined. HBOT might cause improvement in motor skills, attention span, visual and verbal commands.
For this treatment, HBOT is used at “low pressure” (1.5 to 1.7 atmospheres absolute), as this has been demonstrated to be optimal pressure that an injured brain can tolerate without toxicity. A common protocol would be 1.5 ATA for at least 60 minutes once or twice a day for five weeks, along with physical and/or occupational rehabilitation therapy. Assessment of improvement should be done after each cycle of HBOT before to continuing further therapy.